| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Inhibitor Therapeutics Inc (OTCQB: INTI)
INTI Technical Analysis
2.5
| As on 18th Jun 2025 INTI STOCK Price closed @ 0.04 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.06 & Strong Buy for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS. |
INTISTOCK Price
| Open | 0.04 | Change | Price | % |
| High | 0.04 | 1 Day | -0.04 | -50.00 |
| Low | 0.04 | 1 Week | -0.04 | -50.00 |
| Close | 0.04 | 1 Month | -0.05 | -55.56 |
| Volume | 16500 | 1 Year | 0.00 | 0.00 |
| 52 Week High 0.30 | 52 Week Low 0.02 | ||||
OTCQB USA Most Active Stocks
| CNBX | 0.00 | % |
| EMED | 0.00 | % |
| BLEG | 0.00 | % |
| BMIX | 0.01 | % |
| IPSI | 0.00 | % |
| FMCC | 4.94 | 12.53% |
| INVU | 0.02 | 100.00% |
| ALPP | 3.56 | -100.00% |
| ALPP | 3.56 | -100.00% |
| CBDS | 0.06 | -25.00% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| INTI Daily Charts |
INTI Intraday Charts |
Whats New @ Bazaartrend |
INTI Free Analysis |
|
|
INTI Important Levels Intraday
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
INTI Forecast July 2025
| 4th UP Forecast | 0.1 |
| 3rd UP Forecast | 0.08 |
| 2nd UP Forecast | 0.07 |
| 1st UP Forecast | 0.06 |
| 1st DOWN Forecast | 0.02 |
| 2nd DOWN Forecast | 0.01 |
| 3rd DOWN Forecast | 0 |
| 4th DOWN Forecast | -0.02 |
INTI Weekly Forecast
| 4th UP Forecast | 0.08 |
| 3rd UP Forecast | 0.07 |
| 2nd UP Forecast | 0.06 |
| 1st UP Forecast | 0.05 |
| 1st DOWN Forecast | 0.03 |
| 2nd DOWN Forecast | 0.02 |
| 3rd DOWN Forecast | 0.01 |
| 4th DOWN Forecast | 0.00 |
INTI Forecast2025
| 4th UP Forecast | 0.6 |
| 3rd UP Forecast | 0.42 |
| 2nd UP Forecast | 0.31 |
| 1st UP Forecast | 0.2 |
| 1st DOWN Forecast | -0.12 |
| 2nd DOWN Forecast | -0.23 |
| 3rd DOWN Forecast | -0.34 |
| 4th DOWN Forecast | -0.52 |
Inhibitor Therapeutics Inc ( OTCQB USA Symbol : INTI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
INTI Business Profile
Inhibitor Therapeutics, Inc., a pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States. It engages in the development of therapies for prostate and lung cancer utilizing SUBA-Itraconazole, an oral formulation of the drug itraconazole; and conducted a positive Phase 2b study of SUBA-Itraconazole for the treatment of basal cell carcinoma nevus syndrome. The company was formerly known as HedgePath Pharmaceuticals, Inc. and changed its name to Inhibitor Therapeutics, Inc. in August 2019. Inhibitor Therapeutics, Inc. was founded in 1992 and is based in Tampa, Florida. Address: 449 South 12th Street, Tampa, FL, United States, 33602
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service